Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 0.259M
June 30, 2026 0.495M
March 31, 2026 0.441M
December 31, 2025 0.48M
September 30, 2025 0.544M
June 30, 2025 1.099M
March 31, 2025 2.012M
December 31, 2024 9.857M
September 30, 2024 11.14M
June 30, 2024 12.53M
March 31, 2024 13.39M
December 31, 2023 7.541M
Date Value
September 30, 2023 10.29M
June 30, 2023 10.88M
March 31, 2023 11.71M
December 31, 2022 10.94M
September 30, 2022 8.679M
June 30, 2022 6.661M
March 31, 2022 17.82M
December 31, 2021 16.56M
September 30, 2021 14.57M
June 30, 2021 13.77M
March 31, 2021 0.00
December 31, 2020 0.00

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Talphera, Inc. 7.09M
Fortress Biotech, Inc. 2.656M
Relmada Therapeutics, Inc. 33.77M
Turn Therapeutics, Inc. 1.225M
ANI Pharmaceuticals, Inc. 50.60M